IMVT Immunovant, Inc.
Nasdaq · SEC CIK 1764013 · EDGAR
- Bought, last 12 months
- $350.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $15.93M 38 sales by 10 insiders
- Filings on record
- 265 since 2021-08-02, latest 2026-08-28 16:27
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Roivant Sciences Ltd. | Dir, 10% | $350.00M | — |
| Fromkin Andrew J. | Dir | — | $7.96M |
| Stout Jay S | CTO | — | $2.27M |
| Gloria Melanie | COO | — | $1.60M |
| Girao Tiago | CFO | — | $1.41M |
| Van Tuyl Christopher | CLO | — | $1.31M |
| Venker Eric | CEO, Dir | — | $461.8K |
| Pande Atul | Dir | — | $424.6K |
| Hughes Douglas J. | Dir | — | $348.7K |
| Geffner Michael | Chief Medical Off | — | $70.1K |
Transactions 274
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-08-28 16:27 | 2026-08-28 | IMVT | Pande Atul | Dir | S - Sale+OE | $43.27 | -1,500 | 116.7K | -1% | -$64.9K |
| 2026-08-21 16:03 | 2026-08-20 | IMVT | Gloria Melanie | COO | S - Sale | $44.16 | -3,056 | 219.3K | -1% | -$135.0K | |
| DT | 2026-07-24 17:59 | 2026-07-24 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-07-24 17:59 | 2026-07-24 | IMVT | Pande Atul | Dir | S - Sale+OE | $39.80 | -1,500 | 116.7K | -1% | -$59.7K |
| 2026-07-24 17:57 | 2026-07-23 | IMVT | Girao Tiago | CFO | S - Sale | $38.69 | -6,798 | 240.8K | -3% | -$263.0K | |
| 2026-07-24 17:57 | 2026-07-23 | IMVT | Stout Jay S | CTO | S - Sale | $38.69 | -2,857 | 205.3K | -1% | -$110.5K | |
| M | 2026-07-10 16:15 | 2026-07-08 | IMVT | Gloria Melanie | COO | S - Sale | $39.55 | -2,036 | 222.4K | -0.9% | -$80.5K |
| M | 2026-07-10 16:13 | 2026-07-08 | IMVT | Van Tuyl Christopher | CLO | S - Sale | $39.55 | -1,206 | 179.4K | -0.7% | -$47.7K |
| M | 2026-07-10 16:12 | 2026-07-08 | IMVT | Stout Jay S | CTO | S - Sale | $39.55 | -3,487 | 208.2K | -2% | -$137.9K |
| D | 2026-07-06 17:01 | 2026-07-01 | IMVT | Venker Eric | CEO, Dir | M - OptEx | $14.46 | +92.2K | 344.0K | +37% | +$1.33M |
| D | 2026-07-06 17:01 | 2026-07-01 | IMVT | Venker Eric | CEO, Dir | D - Sale to Iss | $38.14 | -86.6K | 257.4K | -25% | -$3.30M |
| D | 2026-07-06 17:01 | 2026-07-02 | IMVT | Venker Eric | CEO, Dir | S - Sale+OE | $38.48 | -3,092 | 254.3K | -1% | -$119.0K |
| M | 2026-06-26 19:46 | 2026-06-26 | IMVT | Gloria Melanie | COO | S - Sale | $38.31 | -17.7K | 224.4K | -7% | -$678.6K |
| M | 2026-06-26 19:45 | 2026-06-26 | IMVT | Stout Jay S | CTO | S - Sale | $38.31 | -40.0K | 211.7K | -16% | -$1.53M |
| D | 2026-06-26 19:45 | 2026-06-26 | IMVT | Van Tuyl Christopher | CLO | M - OptEx | $15.20 | +17.8K | 198.4K | +10% | +$270.9K |
| DM | 2026-06-26 19:45 | 2026-06-26 | IMVT | Van Tuyl Christopher | CLO | S - Sale+OE | $38.31 | -17.8K | 180.6K | -9% | -$682.9K |
| D | 2026-06-26 19:44 | 2026-06-26 | IMVT | Girao Tiago | CFO | M - OptEx | $15.90 | +10.0K | 257.6K | +4% | +$159.0K |
| D | 2026-06-26 19:44 | 2026-06-26 | IMVT | Girao Tiago | CFO | S - Sale+OE | $38.46 | -10.0K | 247.6K | -4% | -$384.6K |
| DT | 2026-06-26 19:43 | 2026-06-26 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-06-26 19:43 | 2026-06-26 | IMVT | Pande Atul | Dir | S - Sale+OE | $38.01 | -1,500 | 116.7K | -1% | -$57.0K |
| 2026-06-22 16:02 | 2026-06-18 | IMVT | Van Tuyl Christopher | CLO | S - Sale | $35.39 | -2,634 | 180.6K | -1% | -$93.2K | |
| DT | 2026-06-16 16:03 | 2026-06-15 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +1,500 | 118.2K | +1% | +$12.6K |
| DT | 2026-06-16 16:03 | 2026-06-15 | IMVT | Pande Atul | Dir | S - Sale+OE | $34.02 | -1,500 | 116.7K | -1% | -$51.0K |
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Fromkin Andrew J. | Dir | M - OptEx | $8.22 | +196.6K | 296.3K | +197% | +$1.62M |
| DM | 2026-05-29 16:04 | 2026-05-28 | IMVT | Fromkin Andrew J. | Dir | S - Sale+OE | $33.51 | -222.0K | 74.4K | -75% | -$7.44M |
| M | 2026-05-22 16:03 | 2026-05-20 | IMVT | Gloria Melanie | COO | S - Sale | $32.45 | -3,115 | 242.1K | -1% | -$101.1K |
| DT | 2026-05-20 21:22 | 2026-05-20 | IMVT | Pande Atul | Dir | M - OptEx | $8.43 | +6,000 | 122.7K | +5% | +$50.6K |
| DT | 2026-05-20 21:22 | 2026-05-20 | IMVT | Pande Atul | Dir | S - Sale+OE | $32.00 | -6,000 | 116.7K | -5% | -$192.0K |
| T | 2026-05-01 18:40 | 2026-05-01 | IMVT | Susman Robert Graham | Dir | S - Sale | $27.17 | -2,502 | 36.4K | -6% | -$68.0K |
| 2026-04-24 16:07 | 2026-04-23 | IMVT | Girao Tiago | CFO | S - Sale | $29.62 | -25.8K | 247.6K | -9% | -$763.0K | |
| 2026-04-24 16:05 | 2026-04-23 | IMVT | Stout Jay S | CTO | S - Sale | $29.62 | -2,754 | 251.7K | -1% | -$81.6K | |
| 2026-04-10 16:05 | 2026-04-08 | IMVT | Van Tuyl Christopher | CLO | S - Sale | $24.83 | -5,165 | 183.2K | -3% | -$128.2K | |
| 2026-04-10 16:03 | 2026-04-08 | IMVT | Gloria Melanie | COO | S - Sale | $24.83 | -8,722 | 245.2K | -3% | -$216.6K | |
| M | 2026-04-10 16:02 | 2026-04-08 | IMVT | Stout Jay S | CTO | S - Sale | $24.83 | -10.1K | 254.4K | -4% | -$251.6K |
| D | 2026-04-09 16:31 | 2026-04-07 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +174.2K | 1.01M | +21% | $0 |
| D | 2026-04-09 16:28 | 2026-04-07 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +13.9K | 99.7K | +16% | $0 |
| D | 2026-04-09 16:26 | 2026-04-07 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +13.9K | 134.7K | +11% | $0 |
| D | 2026-04-09 16:25 | 2026-04-07 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +13.9K | 116.7K | +13% | $0 |
| D | 2026-04-09 16:23 | 2026-04-07 | IMVT | Bauer Jake | Dir | A - Grant | $0.00 | +13.9K | 38.9K | +55% | $0 |
| D | 2026-04-09 16:22 | 2026-04-07 | IMVT | Susman Robert Graham | Dir | A - Grant | $0.00 | +13.9K | 38.9K | +55% | $0 |
| D | 2026-04-09 16:20 | 2026-04-07 | IMVT | Gloria Melanie | COO | A - Grant | $0.00 | +83.7K | 253.9K | +49% | $0 |
| D | 2026-04-09 16:19 | 2026-04-07 | IMVT | Stout Jay S | CTO | A - Grant | $0.00 | +66.9K | 264.6K | +34% | $0 |
| D | 2026-04-09 16:17 | 2026-04-07 | IMVT | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +41.3K | 188.4K | +28% | $0 |
| D | 2026-04-09 16:13 | 2026-04-07 | IMVT | Venker Eric | CEO, Dir | A - Grant | $0.00 | +232.3K | 251.8K | +1,187% | $0 |
| D | 2026-04-09 16:10 | 2026-04-07 | IMVT | Girao Tiago | CFO | A - Grant | $0.00 | +65.0K | 273.4K | +31% | $0 |
| D | 2026-04-03 16:33 | 2026-04-01 | IMVT | Venker Eric | CEO, Dir | M - OptEx | $14.46 | +368.8K | 368.8K | New | +$5.33M |
| D | 2026-04-03 16:33 | 2026-04-01 | IMVT | Venker Eric | CEO, Dir | D - Sale to Iss | $25.10 | -335.0K | 33.8K | -91% | -$8.41M |
| DM | 2026-04-03 16:33 | 2026-04-02 | IMVT | Venker Eric | CEO, Dir | S - Sale+OE | $24.10 | -14.2K | 19.6K | -42% | -$342.9K |
| 2026-03-20 | 2026-03-18 | IMVT | Van Tuyl Christopher | CLO | S - Sale | $24.97 | -2,877 | 147.1K | -2% | -$71.8K | |
| M | 2026-02-27 | 2026-02-25 | IMVT | Gloria Melanie | COO | S - Sale | $27.85 | -3,238 | 172.1K | -2% | -$90.2K |
| 2026-01-23 | 2026-01-21 | IMVT | Stout Jay S | CTO | S - Sale | $26.03 | -1,977 | 197.6K | -1.0% | -$51.5K | |
| M | 2026-01-09 | 2026-01-07 | IMVT | Stout Jay S | CTO | S - Sale | $26.53 | -1,203 | 199.6K | -0.6% | -$31.9K |
| M | 2025-12-19 | 2025-12-18 | IMVT | Van Tuyl Christopher | CLO | S - Sale | $26.91 | -10.8K | 152.2K | -7% | -$290.9K |
| 2025-12-12 | 2025-12-12 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $21.00 | +16.67M | 113.32M | +17% | +$350.00M | |
| M | 2025-12-03 | 2025-12-01 | IMVT | Hughes Douglas J. | Dir | S - Sale | $23.24 | -15.0K | 120.8K | -11% | -$348.7K |
| M | 2025-12-03 | 2025-12-01 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $23.25 | -22.2K | 85.9K | -21% | -$517.2K |
| M | 2025-11-21 | 2025-11-20 | IMVT | Gloria Melanie | COO | S - Sale | $23.62 | -12.6K | 173.5K | -7% | -$298.2K |
| 2025-10-24 | 2025-10-22 | IMVT | Stout Jay S | CTO | S - Sale | $19.03 | -2,520 | 200.8K | -1% | -$48.0K | |
| 2025-10-24 | 2025-10-22 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $19.03 | -2,595 | 218.0K | -1% | -$49.4K | |
| 2025-10-10 | 2025-10-08 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $16.30 | -1,272 | 220.6K | -0.6% | -$20.7K | |
| 2025-10-10 | 2025-10-08 | IMVT | Stout Jay S | CTO | S - Sale | $16.30 | -1,585 | 203.3K | -0.8% | -$25.8K | |
| 2025-07-25 | 2025-07-23 | IMVT | Stout Jay S | CTO | S - Sale | $18.15 | -2,805 | 204.9K | -1% | -$50.9K | |
| 2025-07-25 | 2025-07-23 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $18.15 | -2,385 | 221.8K | -1% | -$43.3K | |
| 2025-07-11 | 2025-07-09 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $17.24 | -1,160 | 224.2K | -0.5% | -$20.0K | |
| 2025-07-11 | 2025-07-09 | IMVT | Stout Jay S | CTO | S - Sale | $17.24 | -1,519 | 207.7K | -0.7% | -$26.2K | |
| D | 2025-05-05 | 2025-05-01 | IMVT | Susman Robert Graham | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2025-05-05 | 2025-05-01 | IMVT | Bauer Jake | Dir | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 |
| D | 2025-05-05 | 2025-05-01 | IMVT | Girao Tiago | CFO | A - Grant | $0.00 | +208.4K | 208.4K | New | $0 |
| 2025-04-25 | 2025-04-23 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $14.79 | -2,349 | 225.4K | -1% | -$34.7K | |
| 2025-04-25 | 2025-04-23 | IMVT | Stout Jay S | CTO | S - Sale | $14.79 | -1,925 | 209.2K | -0.9% | -$28.5K | |
| 2025-04-17 | 2025-04-16 | IMVT | Barnett Eva Renee | CFO | S - Sale | $14.89 | -2,993 | 396.8K | -0.7% | -$44.6K | |
| 2025-04-17 | 2025-04-16 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $14.89 | -8,321 | 1.18M | -0.7% | -$123.9K | |
| M | 2025-04-11 | 2025-04-09 | IMVT | Barnett Eva Renee | CFO | S - Sale | $12.99 | -11.1K | 399.8K | -3% | -$143.7K |
| 2025-04-11 | 2025-04-09 | IMVT | Stout Jay S | CTO | S - Sale | $12.99 | -5,004 | 211.2K | -2% | -$65.0K | |
| 2025-04-11 | 2025-04-09 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $12.99 | -28.1K | 1.19M | -2% | -$364.9K | |
| 2025-04-11 | 2025-04-09 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $12.99 | -6,169 | 227.7K | -3% | -$80.1K | |
| D | 2025-04-03 | 2025-04-01 | IMVT | Barnett Eva Renee | CFO | A - Grant | $0.00 | +88.9K | 410.8K | +28% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Torti Frank | Dir | A - Grant | $0.00 | +199.4K | 835.0K | +31% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Pande Atul | Dir | A - Grant | $0.00 | +16.2K | 102.9K | +19% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Fromkin Andrew J. | Dir | A - Grant | $0.00 | +16.2K | 108.1K | +18% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Van Tuyl Christopher | CLO | A - Grant | $0.00 | +50.8K | 160.7K | +46% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | MIGAUSKY GEORGE V | Dir | A - Grant | $0.00 | +16.2K | 137.3K | +13% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Stout Jay S | CTO | A - Grant | $0.00 | +76.2K | 216.2K | +54% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Hughes Douglas J. | Dir | A - Grant | $0.00 | +16.2K | 135.8K | +14% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Geffner Michael | Chief Medical Off | A - Grant | $0.00 | +101.6K | 233.9K | +77% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Salzmann Peter | CEO, Dir | A - Grant | $0.00 | +265.8K | 1.21M | +28% | $0 |
| D | 2025-04-03 | 2025-04-01 | IMVT | Gloria Melanie | COO | A - Grant | $0.00 | +76.2K | 186.1K | +69% | $0 |
| M | 2025-03-11 | 2025-03-07 | IMVT | Fromkin Andrew J. | Dir | S - Sale | $19.60 | -8,000 | 91.9K | -8% | -$156.8K |
| 2025-02-21 | 2025-02-19 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $20.86 | -15.4K | 948.8K | -2% | -$322.1K | |
| 2025-02-21 | 2025-02-19 | IMVT | Barnett Eva Renee | CFO | S - Sale | $20.86 | -2,814 | 322.0K | -0.9% | -$58.7K | |
| 2025-02-21 | 2025-02-19 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $20.86 | -2,055 | 357.4K | -0.6% | -$42.9K | |
| 2025-01-24 | 2025-01-22 | IMVT | Geffner Michael | Chief Medical Off | S - Sale | $23.59 | -2,657 | 132.3K | -2% | -$62.7K | |
| 2025-01-24 | 2025-01-22 | IMVT | Stout Jay S | CTO | S - Sale | $23.59 | -2,195 | 140.0K | -2% | -$51.8K | |
| M | 2025-01-17 | 2025-01-15 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $23.83 | -8,767 | 964.6K | -0.9% | -$208.9K |
| M | 2025-01-17 | 2025-01-15 | IMVT | Barnett Eva Renee | CFO | S - Sale | $23.83 | -2,298 | 324.8K | -0.7% | -$54.8K |
| M | 2025-01-17 | 2025-01-15 | IMVT | Macias William L. | Chief Medical Off | S - Sale | $23.83 | -2,383 | 359.4K | -0.7% | -$56.8K |
| 2025-01-15 | 2025-01-13 | IMVT | Roivant Sciences Ltd. | Dir, 10% | P - Purchase | $20.00 | +16.85M | 96.65M | +21% | +$336.90M | |
| 2025-01-10 | 2025-01-08 | IMVT | Salzmann Peter | CEO, Dir | S - Sale | $24.10 | -5,105 | 973.0K | -0.5% | -$123.0K | |
| 2025-01-10 | 2025-01-08 | IMVT | Barnett Eva Renee | CFO | S - Sale | $24.10 | -4,105 | 327.1K | -1% | -$98.9K |
Purchase Sale Sale after option exercise All abbreviations